{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:38:48Z","timestamp":1785926328271,"version":"3.56.0"},"reference-count":17,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,9,2]]},"DOI":"10.1080\/14656566.2022.2122710","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:35:05Z","timestamp":1663220105000},"page":"1471-1474","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?"],"prefix":"10.1080","volume":"23","author":[{"given":"Fiammetta","family":"Vanoli","sequence":"first","affiliation":[{"name":"Neuroimmunology and Neuromuscular Disease Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"},{"name":"Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-5737","authenticated-orcid":false,"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[{"name":"Neuroimmunology and Neuromuscular Disease Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011124"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602489"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30392-2"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.08.057"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419832242"},{"key":"cit0007","first-page":"1","volume":"14","author":"Vanoli F","year":"2022","journal-title":"Neurotherapeutics"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25597"},{"key":"cit0010","doi-asserted-by":"crossref","first-page":"e2182","DOI":"10.1212\/WNL.0000000000005692","volume":"90","author":"Nowak RJ","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"cit0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4127","volume":"15","author":"Leandro MJ","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005323"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30369-1"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51376"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1143"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00159-9"},{"key":"cit0017","unstructured":"ClinicalTrials.gov. Efgartigimod expanded access for generalized myasthenia gravis. ClinicalTrials.gov Identifier: NCT04777734. [cited 2022 Sep 13]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04777734"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2122710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T05:57:28Z","timestamp":1672034248000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2122710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":17,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,9,2]]}},"alternative-id":["10.1080\/14656566.2022.2122710"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2122710","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}